Consequently, NF-κB activation exerts dual regulatory roles in tumor immunity through coordinated modulation of both in situ and systemic immune responses, demonstrating context-dependent anti-tumor or pro-tumor outcomes. This evidence concerns the gene NFKB1 and neoplasm.